Efficacy of COVID-19 Oral antivirals in hospitalised oldest-old with high morbidity burden: a target trial emulation study

Keyphrases

• Old Age 100%
• High Morbidity 100%
• Morbidity Burden 100%
• COVID-19 100%
• Target Trial Emulation 100%
• Nirmatrelvir 100%
• Molnupiravir 100%
• Oral Antivirals 100%
• Vaccination Status 60%
• Hospitalized Patients 40%
• Mortality Risk 40%
• Reduced Mortality 40%
• Risk Difference 40%
• Patients with COVID-19 40%
• Confounding Bias 40%
• Older Patients 20%
• Hong Kong 20%
• Wider Public 20%
• Specific Group 20%
• Healthcare Database 20%
• Odds Ratio 20%
• Logistic Regression 20%
• Orally Administered 20%
• Pharmacotherapy 20%
• Public Healthcare 20%
• Treatment Status 20%
• All-cause Mortality 20%
• Weighting Approach 20%
• Inverse Probability Weighting 20%
• Very Old 20%
• Prior Vaccination 20%
• Moderate COVID-19 20%
• Older Hospitalized Patients 20%
• Anti-viral Vaccination 20%
• Mortality Risk Reduction 20%
• Immortal Time Bias 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Ritonavir 100%
• Molnupiravir 100%
• Nirmatrelvir 100%
• Antiviral Drug 100%
• Pharmacotherapy 20%
• All Cause Mortality 20%
• Antivirus Agent 20%

Medicine and Dentistry

• Antiviral Drug 100%